vimarsana.com

Latest Breaking News On - Delap wealth advisory - Page 1 : vimarsana.com

Tripadvisor, Inc (NASDAQ:TRIP) Given Average Rating of Hold by Brokerages

Shares of Tripadvisor, Inc. (NASDAQ:TRIP – Get Free Report) have received a consensus recommendation of “Hold” from the eighteen analysts that are covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and five have issued a buy recommendation on the company. […]

Playtika Holding Corp (NASDAQ:PLTK) Receives $10 30 Consensus Target Price from Brokerages

Shares of Playtika Holding Corp. (NASDAQ:PLTK – Get Free Report) have been assigned a consensus recommendation of “Hold” from the eleven brokerages that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and five have given a buy rating to […]

Wedbush Increases Petco Health and Wellness (NASDAQ:WOOF) Price Target to $4 00

Petco Health and Wellness (NASDAQ:WOOF – Free Report) had its target price raised by Wedbush from $3.00 to $4.00 in a research note published on Thursday morning, Benzinga reports. The firm currently has an outperform rating on the stock. A number of other equities analysts have also recently weighed in on the company. Needham & […]

Atara Biotherapeutics (NASDAQ:ATRA) Given Neutral Rating at HC Wainwright

HC Wainwright reaffirmed their neutral rating on shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. HC Wainwright also issued estimates for Atara Biotherapeutics’ Q2 2024 earnings at $0.06 EPS, Q3 2024 earnings at ($0.28) EPS, Q4 2024 earnings at ($0.28) EPS, FY2024 earnings […]

Atara Biotherapeutics, Inc (NASDAQ:ATRA) Expected to Post Q1 2025 Earnings of ($0 27) Per Share

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Free Report) – Analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Atara Biotherapeutics in a research note issued on Wednesday, May 22nd. HC Wainwright analyst R. Burns expects that the biotechnology company will post earnings of ($0.27) per share for the quarter. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.